Markets

AbbVie Inks Multi-Year Collaboration With McLaren Racing To Be Its Official Pharmaceutical Partner Of McLaren Mastercard Formula 1 Team

Oct 20, 2026 · 07:57 AM ET· updated 1h ago

AbbVie (NYSE:ABBV), a global pharmaceutical leader, and McLaren Racing today announced a multi-year partnership naming AbbVie an Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team. At the center of

Why It Matters

AbbVie, a medicine company, partnered with a famous racing team for several years. When big companies sponsor sports, it shows they have money to spend on growing their brand.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABBV286.18

+3.50 (+1.24%)

MA620.43

+4.03 (+0.65%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.